Chemical Compound Review:
AGN-PC-009DNW 7-[3-(3-cyclohexyl-3-hydroxy- propyl)-2,5...
Synonyms:
AG-H-01784, SureCN9488992, BW-245C, AC1L3OKB, CTK2H7632, ...
- Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. Angeli, V., Staumont, D., Charbonnier, A.S., Hammad, H., Gosset, P., Pichavant, M., Lambrecht, B.N., Capron, M., Dombrowicz, D., Trottein, F. J. Immunol. (2004)
- Action of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew). Kan, K.K., Jones, R.L., Ngan, M.P., Rudd, J.A. Eur. J. Pharmacol. (2003)
- Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Cheng, K., Wu, T.J., Wu, K.K., Sturino, C., Metters, K., Gottesdiener, K., Wright, S.D., Wang, Z., O'neill, G., Lai, E., Waters, M.G. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., Narumiya, S. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. Gervais, F.G., Cruz, R.P., Chateauneuf, A., Gale, S., Sawyer, N., Nantel, F., Metters, K.M., O'neill, G.P. J. Allergy Clin. Immunol. (2001)
- Prostaglandin D2 mediates neuronal protection via the DP1 receptor. Liang, X., Wu, L., Hand, T., Andreasson, K. J. Neurochem. (2005)
- Behavioural, ECoG spectrum power and body temperature effects of BW 245C, a prostaglandin analogue after intraventricular microinjection in chicks. Rotiroti, D., Naccari, F., Nisticò, G. Neuropharmacology (1981)
- Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Minami, T., Okuda-Ashitaka, E., Nishizawa, M., Mori, H., Ito, S. Br. J. Pharmacol. (1997)
- Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2). Orchard, M.A., Ritter, J.M., Shepherd, G.L., Lewis, P.J. British journal of clinical pharmacology. (1983)
- Prostaglandin D2 inhibits fibroblast migration. Kohyama, T., Liu, X.D., Wen, F.Q., Kim, H.J., Takizawa, H., Rennard, S.I. Eur. Respir. J. (2002)
- Further studies on ocular responses to DP receptor stimulation. Woodward, D.F., Spada, C.S., Hawley, S.B., Williams, L.S., Protzman, C.E., Nieves, A.L. Eur. J. Pharmacol. (1993)
- Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype. Protzman, C.E., Woodward, D.F. Invest. Ophthalmol. Vis. Sci. (1990)
- Studies on the ocular pharmacology of prostaglandin D2. Woodward, D.F., Hawley, S.B., Williams, L.S., Ralston, T.R., Protzman, C.E., Spada, C.S., Nieves, A.L. Invest. Ophthalmol. Vis. Sci. (1990)
- Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Yoshimura-Uchiyama, C., Iikura, M., Yamaguchi, M., Nagase, H., Ishii, A., Matsushima, K., Yamamoto, K., Shichijo, M., Bacon, K.B., Hirai, K. Clin. Exp. Allergy (2004)
- Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Ajuebor, M.N., Singh, A., Wallace, J.L. Am. J. Physiol. Gastrointest. Liver Physiol. (2000)
- Prostanoid receptors involved in the relaxation of human pulmonary vessels. Walch, L., Labat, C., Gascard, J.P., de Montpreville, V., Brink, C., Norel, X. Br. J. Pharmacol. (1999)
- Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi, M., Zahavi, J., Kakkar, V.V. Thromb. Haemost. (1984)
- Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. Hamid, S., Whittle, B.J. Br. J. Pharmacol. (1985)
- The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Giles, H., Leff, P., Bolofo, M.L., Kelly, M.G., Robertson, A.D. Br. J. Pharmacol. (1989)
- Characterization of the inhibitory prostanoid receptors on human neutrophils. Wheeldon, A., Vardey, C.J. Br. J. Pharmacol. (1993)
- Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Wright, D.H., Metters, K.M., Abramovitz, M., Ford-Hutchinson, A.W. Br. J. Pharmacol. (1998)
- Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures. Moreau, M., Boileau, C., Martel-Pelletier, J., Brunet, J., Laufer, S., Pelletier, J.P. J. Rheumatol. (2006)
- Prostaglandin D(2) receptor-mediated desensitization of the alpha isoform of the human thromboxane A(2) receptor. Foley, J.F., Kelley, L.P., Kinsella, B.T. Biochem. Pharmacol. (2001)
- Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. Narumiya, S., Toda, N. Br. J. Pharmacol. (1985)
- Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. Monneret, G., Boumiza, R., Gravel, S., Cossette, C., Bienvenu, J., Rokach, J., Powell, W.S. J. Pharmacol. Exp. Ther. (2005)
- Excitatory action of prostanoids on the ferret isolated vagus nerve preparation. Kan, K.K., Jones, R.L., Ngan, M.P., Rudd, J.A. Eur. J. Pharmacol. (2004)
- Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man. Al-Sinawi, L.A., Mekki, Q.A., Hassan, S., Hedges, A., Burke, C., Moody, S.G., O'Grady, J. Prostaglandins (1985)